Project Name: An enhanced approach to faster diagnosis and earlier intervention for those population groups covered by Our Healthier South East London Integrated Care System who are at greatest risk of cardiovascular disease ill health and poor health outcomes.
Project Summary:
Nationally, cardiovascular disease (CVD) claims 160,000 lives a year and is the largest cause of life expectancy gap (13 years in South East London (SEL)) which differentially affects Black, Asian, and Minority Ethnic (BAME) and deprived communities. CVD is often preventable and is the reason it features so prominently in the NHS Long Term Plan.
Our aim is to enable solutions that provide faster diagnosis and earlier intervention for underserved communities who are at greatest risk of cardiovascular (CV) ill health and poor health outcomes. The project aims to:
- Identify the undiagnosed and the undertreated population groups who are at greatest risk of CV ill health
- Understand what factors drive the current behaviours in these population groups
- Co-create solutions with these population groups to provide faster diagnosis and earlier CV intervention
- Implement and measure the outcomes of a scalable solution
- Develop a how-to guide for the implementation of solutions aimed at improving access to healthcare for underserved communities across England
Planned Milestones:
- Kick-off meeting to pull together key stakeholders to discuss and agree an agile project plan, sub project ownership and deliverables.
- Identify the underserved communities at greatest risk of CVD ill Health based on analysis of agreed data sets.
- Use a community engagement partner to work with local leaders within the identified community to understand local needs and obtain qualitative data to support the identification of a population health management intervention.
- Intervention development and implementation. Use the qualitative and quantitative findings to develop a targeted intervention for the identified community (Amendment 1).
- Deployment of CVD bus to take CVD initiatives into the community (Amendment 1).
- Evaluation of intervention and recommendations on system scalability, funding recommendations and sharing of best practice via a how to guide. Outcomes Summary Completed.
Expected Benefits:
Anticipated benefits for patients:
- Faster diagnosis and earlier intervention for their CV health
- Care closer to home
- More equitable access to care
- Tailored CV health information to improve health literacy
Anticipated benefits for the NHS:
- Understanding of the underlying reasons for health inequalities amongst groups within our population in the greatest risk of poor CV health
- More at risk patients treated in timely manner by the NHS
- Supports one of the key priorities set out in the Long Term Plan regarding cardiovascular disease
- Development of a how-to guide that can be replicated in other long-term conditions and supporting the first deployment of such a guide in the second phase solution implementation
- Help to ensure NHS resources can be deployed with maximum efficiency for the underserved communities
Anticipated benefits for Novartis:
- Understanding of the underlying reasons for health inequalities amongst groups within our population in the greatest risk of poor CV health
- Aligns with Novartis’ Health Inequality Pledge
- Publication of the how-to guide and outcomes of the implementation of the Solutions, which Novartis can freely use and share with permission of the CW Partner.
Start Date and Duration: Duration of CWA 24 months from signing of CWA
UK2310104600
Project Name: An enhanced approach to faster diagnosis and earlier intervention for those population groups covered by Our Healthier South East London Integrated Care System who are at greatest risk of cardiovascular disease ill health and poor health outcomes. (SEL CVD Health Inequalities)
Partner Organisation(s): Kings Health Partners and South East London Integrated Care System
Completion Date: 10th June 2024
Outcome Summary:
The SEL CVD Health Inequalities project supported the reduction of health disparities by providing three community-based interventions and over 3000 point of care tests in areas of greatest clinical need. This initiative enhanced early detection and management of cardiovascular disease, resulting in improved access and patient experience.
Outcomes:
- Over 2000 user interaction from the targeted population who had not recently accessed health care services
- Over 3000 point of care diagnostic tests provided, leading to increased health education, improved health literacy and patient empowerment to make better health decisions
- Continued funding of all three interventions
- Implementation of non-medical community-based roles led to improvements in patient experience and clinical efficiency by supporting clinical staff, managing administration and facilitating access to healthcare services
- An evaluation document has been published detailing the project impact and recommendations for the system
Quote from Partner:
“In places across South East London there is a difference in life expectancy of 13 years which CVD plays a major role and disproportionately affects our diverse communities. Working with Novartis we have, with these communities, developed innovative solutions to address these inequalities. The work has been immediately impactful and is being sustained for ongoing benefit. It has been a pleasure to work with the Novartis team and bring the strengths of organisations together. Bring on the next project!!!”
Shaun Danielli - Director of Population Health & Equity
South East London Integrated Care System & Kings Health Partners
Conclusion:
This project has been an example of how different sectors can collaborate effectively to address health inequalities at a local level. Leveraging the resource and expertise of all stakeholders can lead to innovative solutions that increase capacity for healthcare organisation, improve access to healthcare for patients at the greatest need which ultimately improves patient experience and outcomes.
UK2410223587